ArticleOncogene2017
Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies.
H Zhong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it